Suliqua
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Suliqua, covering 2024-10-25 to 2026-07-02. Get the full timeline:
Most recent: EMA Authorised: Suliqua (insulin glargine;lixisenatide) — Sanofi Winthrop Industrie